Molecular Cloning and Expression of Iranian Leishmania major Pteridine Reductase 1
Background: Leishmaniasis is an endemic disease in 88 countries. Reports on Leishmania drug resistance are growing in number. The mechanism of unresponsiveness against glucantime in Iranian cutaneous leishmaniasis has not yet been characterized. To begin the first step in finding an anti-Leishmania...
Main Authors: | N Mosaffa, M Mohebali, F Mahboudi, A Haghighi, M Bandehpour, F Kheirandish, B Kazemi |
---|---|
Format: | Article |
Language: | English |
Published: |
Tehran University of Medical Sciences
2008-04-01
|
Series: | Iranian Journal of Parasitology |
Subjects: | |
Online Access: | http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/9160.pdf&manuscript_id=9160 |
Similar Items
-
Molecular Cloning and Expression of Iranian Leishmania major Pteridine Reductase 1
by: F Kheirandish, et al.
Published: (2008-06-01) -
In Silico Identification and In Vitro Evaluation of Natural Inhibitors of Leishmania major Pteridine Reductase I
by: Fabian C. Herrmann, et al.
Published: (2017-12-01) -
Inhibition of Leishmania Major PTR1 Gene Expression by Anti-sense in Escherichia Coli
by: M Mohebali, et al.
Published: (2012-05-01) -
Inhibition of Leishmania major PTR1 Gene Expression by Anti-sense in Escherichia coli
by: F Kheirandish, et al.
Published: (2012-06-01) -
Dual and selective inhibitors of pteridine reductase 1 (PTR1) and dihydrofolate reductase-thymidylate synthase (DHFR-TS) from Leishmania chagasi
by: Bárbara Velame Ferreira Teixeira, et al.
Published: (2019-01-01)